Anti-amyloid therapies work for Alzheimer's disease
- PMID: 37492486
- PMCID: PMC10365829
- DOI: 10.1093/braincomms/fcad204
Anti-amyloid therapies work for Alzheimer's disease
Conflict of interest statement
J.H. has consulted for Eisai, Roche and Eli Lilly on their Alzheimer programmes.
Comment in
- doi: 10.1093/braincomms/fcad203
Similar articles
-
Anti-Amyloid Therapies for Alzheimer's Disease: An Alzheimer Europe Position Paper and Call to Action.J Prev Alzheimers Dis. 2024;11(2):265-273. doi: 10.14283/jpad.2024.37. J Prev Alzheimers Dis. 2024. PMID: 38374732
-
At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact.J Prev Alzheimers Dis. 2024;11(3):537-548. doi: 10.14283/jpad.2024.60. J Prev Alzheimers Dis. 2024. PMID: 38706270 Clinical Trial.
-
Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.Exp Biol Med (Maywood). 2017 Jul;242(13):1335-1344. doi: 10.1177/1535370217711440. Epub 2017 May 23. Exp Biol Med (Maywood). 2017. PMID: 28534431 Free PMC article.
-
Passive Anti-Amyloid Beta Immunotherapies in Alzheimer's Disease: From Mechanisms to Therapeutic Impact.Biomedicines. 2024 May 15;12(5):1096. doi: 10.3390/biomedicines12051096. Biomedicines. 2024. PMID: 38791059 Free PMC article. Review.
-
Current Anti-Amyloid-β Therapy for Alzheimer's Disease Treatment: From Clinical Research to Nanomedicine.Int J Nanomedicine. 2023 Dec 20;18:7825-7845. doi: 10.2147/IJN.S444115. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38144511 Free PMC article. Review.
Cited by
-
Anti-amyloid therapies do not slow Alzheimer's disease progression.Dement Neuropsychol. 2024 Jan 5;17:e20230099. doi: 10.1590/1980-5764-DN-2023-0099. eCollection 2023. Dement Neuropsychol. 2024. PMID: 38189031 Free PMC article. No abstract available.
-
Eligibility for donanemab trial in a population-based study of cognitive aging.J Prev Alzheimers Dis. 2025 Apr;12(4):100088. doi: 10.1016/j.tjpad.2025.100088. Epub 2025 Feb 17. J Prev Alzheimers Dis. 2025. PMID: 39966022 Free PMC article. Clinical Trial.
References
-
- Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: New insights from new therapeutics. Nat Rev Drug Discov. 2022;21(4):306–318. - PubMed
-
- Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharm. Sci. 1991;12:383–388. - PubMed
-
- Glenner GG. Amyloid beta protein and the basis for Alzheimer's disease. Prog Clin Biol Res. 1989;317:857–868. - PubMed
LinkOut - more resources
Full Text Sources